Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2681 |
|
Actual shortage: | 255 (10%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2417 (90%) | |
Discontinuation Reports |
250 |
|
To be discontinued: | 3 (1%) | |
Discontinued: | 247 (99%) | |
Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
23 (9%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-CEPHALEXIN 125 | 125MG | POWDER FOR SUSPENSION | Resolved | 2022-10-28 | 2024-02-14 | 173037 |
ACT CIPROFLOXACIN | 750MG | TABLET | Resolved | 2022-10-28 | 2023-06-09 | 173040 |
TEVA-CEPHALEXIN 250 | 250MG | POWDER FOR SUSPENSION | Resolved | 2022-10-28 | 2024-02-14 | 173043 |
NOVAMOXIN | 250MG | TABLET (CHEWABLE) | Resolved | 2022-10-28 | 2023-10-04 | 173046 |
TEVA-CEPHALEXIN | 250MG | TABLET | Resolved | 2022-10-28 | 2023-06-09 | 173049 |
TEVA-NYSTATIN | 100000UNIT | SUSPENSION | Resolved | 2022-10-28 | 2022-12-15 | 173052 |
TEVA-PROPRANOLOL | 20MG | TABLET | Resolved | 2022-10-28 | 2023-01-11 | 173055 |
TEVA-EVEROLIMUS | 2.5MG | TABLET | Resolved | 2022-10-28 | 2022-12-08 | 173058 |
TEVA-ATORVASTATIN | 40MG | TABLET | Resolved | 2022-10-28 | 2023-01-12 | 173061 |
APRI 28 | 0.03MG 0.15MG | TABLET | Resolved | 2022-10-28 | 2022-12-02 | 173064 |
APRI 21 | 0.03MG 0.15MG | TABLET | Resolved | 2022-10-28 | 2022-12-02 | 173067 |
TEVA-NAPROXEN | 500MG | TABLET | Resolved | 2022-11-14 | 2023-01-19 | 174583 |
TEVA-ATORVASTATIN | 20MG | TABLET | Resolved | 2022-11-14 | 2023-01-12 | 174586 |
TEVA-ATORVASTATIN | 10MG | TABLET | Resolved | 2022-11-14 | 2023-04-28 | 174589 |
DOXORUBICIN HYDROCHLORIDE INJECTION | 2MG | SOLUTION | Resolved | 2022-11-14 | 2023-01-12 | 174595 |
TEVA-CARVEDILOL | 3.125MG | TABLET | Resolved | 2022-11-14 | 2023-02-09 | 174598 |
TEVA-CARVEDILOL | 6.25MG | TABLET | Resolved | 2022-11-14 | 2023-02-09 | 174601 |
TEVA-RAMIPRIL | 10MG | CAPSULE | Resolved | 2022-11-14 | 2023-02-02 | 174604 |
ETOPOSIDE INJECTION | 20MG | LIQUID | Resolved | 2022-11-14 | 2023-02-09 | 174607 |
TEVA-ATENOLOL | 50MG | TABLET | Resolved | 2022-11-14 | 2023-10-05 | 174610 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64544 | ||
TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64547 | ||
TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64550 | ||
TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64553 | ||
RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64589 | ||
RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64592 | ||
RATIO-MEMANTINE | Discontinued | 2018-10-17 | 2018-10-17 | 64595 | ||
RATIO-MEMANTINE | Discontinued | 2018-10-17 | 2018-10-17 | 64598 | ||
TEVA-ATORVASTATIN | 10MG | TABLET | Discontinued | 2018-10-17 | 2018-10-17 | 64601 |
TEVA-ATORVASTATIN | 10MG | TABLET | Discontinued | 2018-10-17 | 2018-10-17 | 64606 |
TEVA-ATORVASTATIN | 20MG | TABLET | Discontinued | 2018-10-17 | 2018-10-17 | 64609 |
TEVA-ATORVASTATIN | 20MG | TABLET | Discontinued | 2018-10-17 | 2018-10-17 | 64612 |
RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64615 | ||
RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64623 | ||
RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64626 | ||
TEVA-QUETIAPINE | 100MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64846 |
TEVA-QUETIAPINE | 25MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64849 |
RATIO-ATORVASTATIN | Discontinued | 2018-10-19 | 2018-10-19 | 64852 | ||
TEVA-ENALAPRIL | 8MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64855 |
TEVA-ENALAPRIL | 8MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64858 |